Discover
ALT
Altimmune, Inc.
2.61
2 x 2.24
2 x 3.92
bid
ask
+
0.01
0.38%
2 @ 05:19 PM
2.64 +0.03 (1.12%)
| Ytd | -27.70% | |
| 1y | -34.75% |
2.57
day range
2.64
2.59
52 week range
6.18
| Open | 2.60 | Prev Close | 2.60 | Low | 2.57 | High | 2.64 | Mkt Cap | 507.69M |
| Vol | 2.68M | Avg Vol | 4.21M | EPS | -0.76 | P/E | N/A | Forward P/E | -5.14 |
| Beta | 0.07 | Short Ratio | 5.81 | Inst. Own | 56.68% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | 01-20 | Earning | 11-05 | 50-d Avg | 3.07 | 200-d Avg | 3.42 | 1yr Est | 22.86 |
| Income Statement | |||
| Operating Expenses | 26.23M | ||
| Research and Development Expense | 18.66M | ||
| Selling, General and Administrative Expense | 7.57M | ||
| Operating Income | -26.23M | ||
| Interest Expense | 1.10M | ||
| Net Income | -22.82M | ||
| Net Income Common Stock | -22.82M | ||
| Net Income Common Stock (USD) | -22.82M | ||
| Consolidated Income | -22.82M | ||
| Earnings per Basic Share | -0.12 | ||
| Earnings per Basic Share (USD) | -0.12 | ||
| Earnings per Diluted Share | -0.12 | ||
| Earning Before Interest & Taxes (EBIT) | -21.73M | ||
| Earning Before Interest & Taxes (USD) | -21.73M | ||
| Weighted Average Shares | 185.44M | ||
| Weighted Average Shares Diluted | 185.44M | ||
| Balance Sheet | |||
| Cash and Equivalents | 63.05M | ||
| Cash and Equivalents (USD) | 63.05M | ||
| Investments | 455.52M | ||
| Investments Current | 263.27M | ||
| Investments Non-Current | 192.25M | ||
| Trade and Non-Trade Receivables | 3.34M | ||
| Current Assets | 334.82M | ||
| Property, Plant & Equipment Net | 60.00K | ||
| Total Assets | 527.21M | ||
| Total Debt | 34.74M | ||
| Current Liabilities | 12.50M | ||
| Debt Non-Current | 34.74M | ||
| Total Liabilities | 53.00M | ||
| Accumulated Retained Earnings (Deficit) | -694.87M | ||
| Accumulated Other Comprehensive Income | -6.04M | ||
| Shareholders Equity | 474.21M | ||
| Shareholders Equity (USD) | 474.21M | ||
| Assets Non-Current | 192.40M | ||
| Total Debt (USD) | 34.74M | ||
| Liabilities Non-Current | 40.50M | ||
| Trade and Non-Trade Payables | 1.27M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 23.00K | ||
| Net Cash Flow from Financing | 211.07M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -34.59M | ||
| Capital Expenditure | -32.00K | ||
| Issuance (Purchase) of Equity Shares | 210.80M | ||
| Net Cash Flow from Investing | -221.44M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -221.41M | ||
| Net Cash Flow from Operations | -24.22M | ||
| Share Based Compensation | 2.79M | ||